Ignite Creation Date:
2024-05-06 @ 3:31 AM
Last Modification Date:
2024-10-26 @ 11:34 AM
Study NCT ID:
NCT02302742
Status:
RECRUITING
Last Update Posted:
2023-05-09
First Post:
2014-11-11
Brief Title:
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
Sponsor:
Organization:
University of Kansas Medical Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
10 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
A baseline blood draw is collected as a part of this registry If a study participant has a personal history of cancer and a tumor sample is available the participant may give consent for the tissue to be used as a part of the study Additional optional specimen collection sub-studies may also be offered to participants
Enrollment Count:
1500
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 28126 |
Who Masked List: